Article contents
Nutritional Aspects of Aluminium Toxicity
Published online by Cambridge University Press: 14 December 2007
Abstract
An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
- Type
- Research Article
- Information
- Copyright
- Copyright © The Nutrition Society 1990
References
REFERENCES
Ackrill, P., Ralston, A. J. & Day, J. P. (1986). Role of desferrioxamine in the treatment of dialysis encephalopathy. Kidney International 29 Suppl 18, S104–S107.Google Scholar
Alfrey, A. C. (1983). Aluminum. Advances in Clinical Chemistry 23, 69–91.CrossRefGoogle ScholarPubMed
Alfrey, A. C. (1985). The case against aluminum affecting parathyroid function. American Journal of Kidney Diseases 6, 309–312.CrossRefGoogle ScholarPubMed
Alfrey, A. C. (1986). Dialysis encephalopathy. Kidney International 29, Suppl. 18, S53–S57.Google Scholar
Alfrey, A. C., Hegg, A. & Craswell, P. (1980). Metabolism and toxicity of aluminum in renal failure. American Journal of Clinical Nutrition 33, 1509–1516.CrossRefGoogle ScholarPubMed
Alfrey, A. C., LeGendre, G. R. & Kaehny, W. D. (1976). The dialysis encephalopathy syndrome. Possible aluminum intoxication. New England Journal of Medicine 294, 184–188.CrossRefGoogle ScholarPubMed
Alfrey, A. C., Mishell, M., Burks, J., Contiguglia, S. R., Rudolph, H., Lewin, E. & Holmes, J. H. (1972). Syndrome of dyspraxia and multifocal seizures associated with chronic hemodialysis. Transactions of the American Society for Artificial Internal Organs 18, 257–261.CrossRefGoogle ScholarPubMed
Andreoli, S. P., Bergstein, J. M. & Sherrard, D. J. (1984). Aluminum intoxication from aluminum-containing phosphate binders in children with azotemia not undergoing dialysis. New England Journal of Medicine 310, 1079–1084.CrossRefGoogle Scholar
Andress, D., Felsenfeld, A. J., Voigts, A. & Llach, F. (1983). Parathyroid hormone response to hypocalcemia in hemodialysis patients with osteomalacia. Kidney International 24, 364–370.CrossRefGoogle ScholarPubMed
Andress, D. L., Ott, S. M., Maloney, N. A. & Sherrard, D. J. (1985). Effect of parathyroidectomy on bone aluminum accumulation in chronic renal failure. New England Journal of Medicine 312, 468–473.CrossRefGoogle Scholar
Bakir, A. A., Hryhorczuk, D. D., Berman, E. & Dunea, G. (1986). Acute fatal hyperaluminemic encephalopathy in undialyzed and recently dialyzed uremic patients. Transactions of the American Society for Artificial Internal Organs 32, 171–176.Google ScholarPubMed
Balistreri, W. F., Novak, D. A. & Farrell, M. K. (1986). Bile acid metabolism, total parenteral nutrition, and cholestasis. In Total Parenteral Nutrition: Indications, Utilization, Complications, and Pathophysiological Considerations, pp. 319–334 [Lebenthal, E., editor]. New York: Raven Press.Google Scholar
Banks, W. A. & Kastin, A. J. (1983). Aluminium increases permeability of the blood–brain barrier to labelled DSIP and β-endorphin: possible implications for senile and dialysis dementia. Lancet ii, 1227–1229.CrossRefGoogle Scholar
Bengoa, J. M., Sitrin, M. D., Wood, R. J. & Rosenberg, I. H. (1983). Amino acid-induced hypercalciuria in patients on total parenteral nutrition. American Journal of Clinical Nutrition 38, 264–269.CrossRefGoogle ScholarPubMed
Bidlack, W. R., Brown, R. C., Meskin, M. S., Lee, T. C. & Klein, G. L. (1987). Effect of aluminum on the hepatic mixed function oxidase and drug metabolism. Drug–Nutrient Interactions 5, 33–42.Google ScholarPubMed
Blair, H. C., Finch, J. L., Avioli, R., Crouch, E. C., Slatopolsky, E. & Teitelbaum, S. L. (1989). Micromolar aluminum levels reduce 3H-thymidine incorporation by cell line UMR 106-01. Kidney International 35, 1119–1125.CrossRefGoogle ScholarPubMed
Bourdeau, A. M., Plachot, J. J., Cournot-Witmer, G., Pointillart, A., Balsan, S. & Sachs, C. (1987). Parathyroid response to aluminum in vitro: ultrastructural changes andPTH release. Kidney International 31 15–24.CrossRefGoogle ScholarPubMed
Bournerais, F., Monnier, N. & Reveillaud, R. J. (1983). Risk of orally administered aluminum hydroxide and results of withdrawal. Proceedings of the European Dialysis and Transplantation Association 20, 207–212.Google Scholar
Brun, A. & Dictor, M. (1981). Senile plaques and tangles in dialysis dementia. Acta Pathologica et Microbiologica Scandinavica A 89, 193–198.Google ScholarPubMed
Buchanan, M. R. C., Ihle, B. U. & Dunn, C. M. (1981). Hemodialysis related osteomalacia: a staining method to demonstrate aluminum. Journal of Clinical Pathology 34, 1352–1354.CrossRefGoogle Scholar
Burks, J. S., Alfrey, A. C., Huddleston, J., Norenberg, M. D. & Lewin, E. (1976). A fatal encephalopathy in chronic haemodialysis patients. Lancet i, 764–768.CrossRefGoogle Scholar
Cann, C. E., Prussin, S. G. & Gordan, G. S. (1979). Aluminum uptake by the parathyroid glands. Journal of Clinical Endocrinology and Metabolism 49, 543–545.CrossRefGoogle ScholarPubMed
Carlisle, E. M. & Curran, M. J. (1987). Interrelationship between silicon and aluminum in the rat. Federation Proceedings 46, 755 Abstr.Google Scholar
Carmichael, K. A., Fallon, M. D., Dalinka, M., Kaplan, F. S., Axel, L. & Haddad, J. G. (1984). Osteomalacia and osteitis fibrosa in a man ingesting aluminum hydroxide antacid. American Journal of Medicine 76, 1137–1143.CrossRefGoogle Scholar
Chan, Y. L., Alfrey, A. C., Posen, S., Lissner, D., Hills, E., Dunstan, C. R. & Evans, R. A. (1983). Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites and quantitative bone histology. Calcified Tissue International 35, 344–351.CrossRefGoogle ScholarPubMed
Clarkson, E. M., Luck, V. A., Hynson, W. V., Bailey, R. R., Eastwood, J. B., Woodhead, J. S., Clements, V. R., O'Riordan, J. L. H. & de Wardener, H. E. (1972). The effect of aluminium hydroxide on calcium, phosphorus, and aluminium balances, the serum parathyroid hormone concentration and the aluminium content of bone in patients with chronic renal failure. Clinical Science 43, 519–531.CrossRefGoogle ScholarPubMed
Committee on Nutrition, American Academy of Pediatrics (1986). Aluminum toxicity in infants and children. Pediatrics 78, 1150–1154.Google Scholar
Cournot-Witmer, G., Zingraff, J., Plachot, J. J., Escaig, F., Lefèvre, R., Boumati, P., Bourdeau, A., Garabèdian, M., Galle, P., Bourdon, R., Drüeke, T. & Balsan, S. (1981). Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization. Kidney International 20, 375–385.CrossRefGoogle ScholarPubMed
Crapper, D. R., Quittkat, S., Krishnan, S. S., Dalton, A. J. & De Boni, U. (1980). Intranuclear aluminum content in Alzheimer's disease, dialysis encephalopathy, and experimental aluminum encephalopathy. Acta Neuropathologica 50, 19–24.CrossRefGoogle ScholarPubMed
DeBoni, U., Seger, M. & McLachlan, Crapper D. R. (1980). Functional consequences of chromatin bound aluminum in cultured human cells. Neurotoxicology 1, 65–81.Google Scholar
Demontis, R., Reissi, D., Boudailliez, B., Westeel, P. F., Leflon, P., Brasseur, J., Coevoet, B. & Fournier, A. (1989). Indirect clinical evidence that 1-αOH vitamin D3 increases the intestinal absorption of aluminum. Clinical Nephrology 31, 123–127.Google ScholarPubMed
deVernejoul, M. C., Messing, B., Modrowski, D., Bielakoff, J., Buisine, A. & Miravet, L. (1985). Multifactorial low remodeling bone disease during cyclic total parenteral nutrition. Journal of Clinical Endocrinology and Metabolism 60, 109–113.CrossRefGoogle Scholar
DiJoseph, J. F., Borella, L. E. & Mir, Nabi G. (1989). Activated aluminum complex derived from solubilized antacids exhibits enhanced cytoprotective activity in rat. Gastroenterology 96, 730–735.CrossRefGoogle Scholar
Ellis, H. A., McCarthy, J. H. & Herrington, J. (1979). Bone aluminum in hemodialyzed patients and in rats injected with aluminum chloride: relationship to impaired bone mineralization. Journal of Clinical Pathology 32, 832–844.CrossRefGoogle Scholar
Fanti, P., Faugere, M. C., Smith, A. J. & Malluche, H. H. (1987). Removal of aluminum (Al) is associated with increased production of 1,25(OH)2 vit D in dialysis patients. Kidney International 31, 346 Abstr.Google Scholar
Fell, G. S., Shenkin, A. & Halls, D. J. (1986). Aluminium contamination of intravenous pharmaceuticals, nutrients, and blood products. Lancet i, 380.CrossRefGoogle Scholar
Felsenfeld, A. J., Rodriguez, M., Coleman, M., Ross, D. & Llach, F. (1989). Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease. Kidney International 35, 1371–1378.CrossRefGoogle ScholarPubMed
Fisher, C. E., Knowles, M. E., Massey, R. C. & McWeeny, D. J. (1989). Levels of aluminium in infant formulae. Lancet i, 1024.CrossRefGoogle Scholar
Freundlich, M., Zilleruelo, G., Abitbol, C., Strauss, J., Faugere, M.-C. & Malluche, H. H. (1985). Infant formula as a cause of aluminium toxicity in neonatal uraemia. Lancet ii, 527–529.CrossRefGoogle Scholar
Galceran, T. J., Finch, J., Bergfeld, M., Coburn, J. W., Teitelbaum, S., Martin, K. & Slatopolsky, E. (1987). Biological effects of aluminum on normal dogs: studies on isolated perfused bone. Endocrinology 121, 406–413.CrossRefGoogle ScholarPubMed
Galle, P. & Giudicelli, C. P. (1982). [Electron microprobe ultrastructural localization of aluminium in hepatocytes. Nouvelle Presse Médicale 11, 1123–1125.Google ScholarPubMed
Garruto, R. M., Yanagihara, R., Shankar, S., Wolff, A., Salazar, A. M., Amyx, H.L. & Gajdusek, D. C. (1988). Experimental models of metal-induced neurofibrillary degeneration. In Amyotrophic Lateral Sclerosis, pp. 41–50. [Tsubaki, T. and Yase, Y., editors]. Amsterdam: ElsevierScience Publishers.Google ScholarPubMed
Glinert, R. J. & Burnatowska-Hledin, M. (1988). Serum and urinary aluminum levels in patients receiving alumprecipitated allergenic extracts. Annals of Allergy 61, 433–435.Google Scholar
Godsall, J. W., Baron, R. & Insogna, K. L. (1984). Vitamin D metabolism and bone histomorphometry in a patient with antacid-induced osteomalacia. American Journal of Medicine 77, 747–750.CrossRefGoogle Scholar
Goodman, W. G. (1984). Short-term aluminum administration in the rat: reductions in bone formation without osteomalacia. Journal of Laboratory and Clinical Medicine 103, 749–757.Google ScholarPubMed
Goodman, W. G., Gilligan, J. & Horst, R. L. (1984 a). Short-term aluminum administration in the rat: effects on bone formation and relationship to renal osteomalacia. Journal of Clinical Investigation 73, 171–181.CrossRefGoogle Scholar
Goodman, W. G., Henry, D. A., Horst, R. L., Nudelman, R. K., Alfrey, A. C. & Coburn, J. W. (1984 b). Parenteral aluminum administration in the dog. II. Induction of osteomalacia and effect on vitamin D metabolism. Kidney International 25, 370–375.CrossRefGoogle ScholarPubMed
Gorsky, J. E., Dietz, A. A., Spencer, H. & Osis, D. (1979). Metabolic balance of aluminum studied in six men. Clinical Chemistry 25, 1739–1743.Google ScholarPubMed
Greger, J. L. & Baier, M. J. (1983 a). Excretion and retention of low or moderate levels of aluminium by human subjects. Food and Chemical Toxicology 21, 473–476.CrossRefGoogle ScholarPubMed
Greger, J. L. & Baier, M. J. (1983 b). Effect of dietary aluminum on mineral metabolism of adult males. American Journal of Clinical Nutrition 38, 411–419.CrossRefGoogle ScholarPubMed
Hem, J. D. (1986). Geochemistry and aqueous chemistry of aluminum. Kidney International 29, Suppl. 18, S3–S7.Google Scholar
Henry, D. A., Goodman, W. G., Nudelman, R. K., DiDomenico, N. D., Alfrey, A. C., Slatopolsky, E. & Coburn, J. W. (1984). Parenteral aluminum administration in the dog. I. Plasma kinetics, tissue levels, calcium metabolism and parathyroid hormone. Kidney International 25, 362–369.CrossRefGoogle ScholarPubMed
Henry, H. L. & Norman, A. W. (1985). Interactions between aluminum and the actions and metabolism of vitamin D3 in the chick. Calcified Tissue International 37, 484–487.CrossRefGoogle ScholarPubMed
Hodsman, A. B., Sherrard, D. J., Wong, E. G. C., Brickman, A. S., Lee, D. B. N., Alfrey, A. C., Singer, F. R., Norman, A. W. & Coburn, J. W. (1981). Vitamin D resistant osteomalacia in hemodialysis patients lacking secondary hyperparathyroidism: description of the syndrome in 19 patients. Annals of Internal Medicine 94, 629–637.CrossRefGoogle Scholar
Ittel, T. H., Buddington, B., Miller, N. L. & Alfrey, A. C. (1987). Enhanced gastrointestinal absorption of aluminum in uremic rats. Kidney International 32, 821–826.CrossRefGoogle ScholarPubMed
Ittel, T. H., Kluge, R. & Sieberth, H. G. (1988). Enhanced gastrointestinal absorption of aluminum in uraemia: time course and effect of vitamin D. Nephrology, Dialysis, Transplantation 3, 617–623.CrossRefGoogle ScholarPubMed
Jeffery, E. H., Jansen, H. T. & Dellinger, J. A. (1987). In vivo interactions of aluminum with hepatic cytochrome P-450 and metallothionein. Fundamental and Applied Toxicology 8, 541–548.CrossRefGoogle ScholarPubMed
Kaehny, W. D., Hegg, A. P. & Alfrey, A. C. (1977). Gastrointestinal absorption of aluminum from aluminum-containing antacids. New England Journal of Medicine 296, 1389–1390.CrossRefGoogle ScholarPubMed
Kirschbaum, B. B. & Schoolwerth, A. C. (1989). Acute aluminum toxicity associated with oral citrate and aluminum-containing antacids. American Journal of Medical Sciences 297, 9–11.CrossRefGoogle ScholarPubMed
Klatzo, I., Wisniewski, H. & Streicher, E. (1965). Experimental production of neurofibrillary degeneration. I. Light microscopic observations. Journal of Neuropathology and Experimental Neurology 24, 187–199.CrossRefGoogle ScholarPubMed
Klein, G. L. (1990). Unusual sources of aluminum. In Aluminum and Renal Failure, pp. 203–211 [DeBroe, M. E. and Coburn, J. W., editors]. Dordrecht: Kluwer Academic Publishers.CrossRefGoogle Scholar
Klein, G. L., Alfrey, A. C., Miller, N. L., Sherrard, D. J., Hazlet, T. K., Ament, M. E. & Coburn, J. W. (1982 a). Aluminum loading during total parenteral nutrition. American Journal of Clinical Nutrition 35, 1425–1429.CrossRefGoogle ScholarPubMed
Klein, G. L., Ament, M. E., Slatopolsky, E. & Coburn, J. W. (1985 a). Urinary mineral excretion during long-term total parenteral nutrition. In Metabolic Bone Disease in Total Parenteral Nutrition, pp. 103–128 [Coburn, J. W. and Klein, G. L., editors]. Baltimore/Munich: Urban and Schwarzenberg.Google ScholarPubMed
Klein, G. L., Berquist, W. E., Ament, M. E., Coburn, J. W., Miller, N. L. & Alfrey, A. C. (1984). Hepatic aluminum accumulation in children on total parenteral nutrition. Journal of Pediatric Gastroenterology and Nutrition 3, 740–743.CrossRefGoogle ScholarPubMed
Klein, G. L., Heyman, M. B., Lee, T. C., Miller, N. L., Marathe, G., Gourley, W. K. & Alfrey, A. C. (1988). Aluminum associated hepatobiliary dysfunction in rats: relationships to dosage and duration of exposure. Pediatric Research 23, 275–278.CrossRefGoogle ScholarPubMed
Klein, G. L., Horst, R. L., Alfrey, A. C. & Slatopolsky, E. (1985 b). Serum levels of 1,25-dihydroxyvitamin D in children on parenteral nutrition with reduced aluminum content. Journal of Pediatric Gastroenterology and Nutrition 4, 93–96.CrossRefGoogle ScholarPubMed
Klein, G. L., Horst, R. L., Norman, A. W., Ament, M. E., Slatopolsky, E. & Coburn, J. W. (1981). Reduced serum levels of 1-alpha,25-dihydroxy vitamin D during long-term total parenteral nutrition. Annals of Internal Medicine 94, 638–643.CrossRefGoogle Scholar
Klein, G. L., Horst, R. L., Slatopolsky, E., Kurokawa, K., Alfrey, A. C., Ament, M. E. & Coburn, J. W. (1985 c). Attempts to modify PTH and vitamin D status in patients receiving long-term total parenteral nutrition. In Metabolic Bone Disease in Total Parenteral Nutrition, pp. 91–100. [Coburn, J. W. and Klein, G. L., editors]. Baltimore/Munich: Urban and Schwarzenberg.Google ScholarPubMed
Klein, G. L., Lee, T. C., Bishop, J. E., Vaccaro, M. L., Jongen, M., Kurokawa, K., Coburn, J. W. & Norman, A. W. (1986). The effects of aluminum loading on the renal response to parathyroid hormone in the vitamin D-replete rat. Biochemical Medicine and Metabolic Biology 36, 363–368.CrossRefGoogle ScholarPubMed
Klein, G. L., Lee, T. C., Heyman, M. B. & Rassin, D. K. (1989 b). Altered glycine and taurine conjugation of bile acids following aluminum administration to rats. Journal of Pediatric Gastroenterology and Nutrition 9, 361–364.CrossRefGoogle ScholarPubMed
Klein, G. L., Lee, T. C., Mann, P. A., Miller, N. L. & Alfrey, A. C. (1989 a). Effects of aluminum on the liver following high-dose enteral administration to rats. Journal of Pediatric Gastroenterology and Nutrition 9, 105–107.CrossRefGoogle ScholarPubMed
Klein, G. L., Ott, S. M., Alfrey, A. C., Sherrard, D. J., Hazlet, T. K., Miller, N. L., Maloney, N. A., Berquist, W. E., Ament, M. E. & Coburn, J. W. (1982 b). Aluminum as a factor in the bone disease of long-term parenteral nutrition. Transactions of the Association of American Physicians 95, 155–164.Google ScholarPubMed
Klein, G. L., Sedman, A. B., Heyman, M. B., Marathe, G., Battifora, H. A., Worrall, J. L., Horst, R. L., Brewer, G. J., Miller, N. L. & Alfrey, A. C. (1987). Hepatic abnormalities associated with aluminum loading in piglets. Journal of Parenteral and Enteral Nutrition 11, 293–297.CrossRefGoogle ScholarPubMed
Klein, G. L., Sedman, A. B., Merritt, R. J. & Alfrey, A. C. (1985 d). Tissue aluminum loading in premature infants on intravenous therapy: a possible cause of osteopenia. Clinical Research 33, 140A Abstr.Google Scholar
Klein, G. L., Snodgrass, W. R., Griffin, M. P., Miller, N. L. & Alfrey, A. C. (1989 c). Hypocalcemia complication deferoxamine therapy in an infant with parenteral nutrition-associated aluminum overload: evidence for a role of aluminum in the bone disease of infants. Journal of Pediatric Gastroenterology and Nutrition 9, 400–403.CrossRefGoogle Scholar
Klein, G. L., Targoff, C. M., Ament, M. E., Sherrard, D. J., Bluestone, R., Young, J. H., Norman, A. W. & Coburn, J. W. (1980). Bone disease associated with total parenteral nutrition. Lancet ii, 1041–1044.CrossRefGoogle Scholar
Koo, W. W. K., Kaplan, L. A., Bendon, R., Succop, P., Tsang, R. C., Horn, J. & Steichen, J. J. (1986 b). Response to aluminum in parenteral nutrition during infancy. Journal of Pediatrics 109, 883–887.CrossRefGoogle ScholarPubMed
Koo, W. W. K., Kaplan, L. A., Horn, J., Tsang, R. C. & Steichen, J. J. (1986 c). Aluminum in parenteral solutions – sources and possible alternatives. Journal of Parenteral and Enteral Nutrition 10, 591–595.CrossRefGoogle ScholarPubMed
Koo, W. W. K., KaplanL, A. & Krug-Wispe, S. K. (1988). Aluminum contamination of infant formulas. Journal of Parenteral and Enteral Nutrition 12, 170–173.CrossRefGoogle ScholarPubMed
Koo, W. W. K., Oestreich, A., Tsang, R. C., Sherman, R. & Steichen, J. (1986 a). Natural history of rickets and fractures in very low birth weight (VLBW) infants during infancy. Journal of Bone and Mineral Research 1, 123 Abstr. 255.Google Scholar
Kopeloff, L. M., Barrera, S. E. & Kopeloff, N. (1942). Recurrent convulsive seizures in animals produced by immunologic and chemical means. American Journal of Psychiatry 98, 881–902.CrossRefGoogle Scholar
Kovalchik, M. T., Kaehny, W. D., Jackson, T. & Alfrey, A. C. (1978). Aluminum kinetics during hemodialysis. Journal of Laboratory and Clinical Medicine 92, 712–716.Google Scholar
Kraut, J. A., Shinaberger, J. H., Singer, F. R., Sherrard, D. J., Saxton, J., Miller, J. H., Kurokawa, K. & Coburn, J. W. (1983). Parathyroid gland responsiveness to acute hypocalcemia in dialysis osteomalacia. Kidney International 23, 725–730.CrossRefGoogle ScholarPubMed
Lawson, M., Milla, P. J. & Harper, J. L. (1989). Aluminium and infant formulae. Lancet i, 614–615.CrossRefGoogle Scholar
Lewis-Finch, J., Bergfeld, M., Martin, K., Teitelbaum, S. & Slatopolsky, E. (1986). Hypoparathyroidism is essential for development of aluminum-induced osteomalacia in rats. Kidney International 29, 218 Abstr.Google Scholar
Lieberherr, M., Grosse, B., Cournot-Witmer, G., Herman-Erlee, M. P. M. & Balsan, S. (1987). Aluminum action on mouse bone cell metabolism and response to PTH and 1,25 (OH)2D3. Kidney International 31, 736–743.CrossRefGoogle ScholarPubMed
Litov, R. E., Sickles, V. S., Chan, G. M., Springer, M. A. & Cordano, A. (1989). Plasma aluminum measurements in term infants fed human milk or a soy-based infant formula. Pediatrics 84, 1105–1107.Google ScholarPubMed
Llach, F., Felsenfeld, A. J., Coleman, M. D., Keveney, J. J., Pederson, J. A. & Medlock, T. R. (1986). The natural course of dialysis osteomalacia. Kidney International 29, Suppl. 18, S74–S79.Google Scholar
London, G. M., deVernejoul, M. C., Fabiani, F., Marchais, S., Guerin, A., Metivier, F., Chappais, P. & Llach, F. (1989). Association between aluminum accumulation and cardiac hypertrophy in hemodialyzed patients. American Journal of Kidney Diseases 13, 75–83.CrossRefGoogle ScholarPubMed
Long, J. F., Nagode, L. A., Kindig, O. & Liss, L. (1980). Axonal swellings of Purkinje cells in chickens associated with high intake of 1,25(OH)2D3 and elevated dietary aluminum includingx-ray microanalysis. Neurotoxicology 1, 111–120.Google Scholar
McGraw, M., Bishop, N., Jameson, R., Robinson, M. J., O'Hara, M., Hewitt, C. D. & Day, J. P. (1986). Aluminum content of milk formulae and intravenous fluids used in infants. Lancet i, 157.CrossRefGoogle Scholar
Malluche, H. H., Faugere, M.-C., Friedler, R. M., Matthews, C. & Fanti, P. (1987). Calcitriol, parathyroid hormone, and accumulation of aluminum in bone in dogs with renal failure. Journal of Clinical Investigation 79, 754–761.CrossRefGoogle ScholarPubMed
Marquis, J. K. & Black, E. E. (1984). Aluminum activation and inactivation of bovine caudate acetyl-cholinesterase. Bulletin of Environmental Contamination and Toxicology 32, 704–710.CrossRefGoogle Scholar
Martin, R. B., Savory, J., Brown, S., Bertholf, R. L. & Wills, M. R. (1987). Transferrin binding of Al3+ and Fe3+. Clinical Chemistry 33, 405–407.Google ScholarPubMed
Martyn, C. N., Barker, D. J. P., Osmond, C., Harris, E. C., Edwardson, J. A. & Lacey, R. F. (1989). Geographical relation between Alzheimer's disease and aluminium in drinking water. Lancet i, 59–62.Google Scholar
May, J. C., Rains, T. C., Maienthal, F. J., Biddle, G. N. & Progar, J. J.(1986). A survey of the concentrations of eleven metals in vaccines, allergenic extracts, toxoids, blood, blood derivatives and other biological products. Journal of Biological Standardization 14, 363–375.CrossRefGoogle ScholarPubMed
Mayor, G. H., Keiser, J. A., Makadons, D. & Ku, P. (1977). Aluminum absorption and distribution: effect of parathyroid hormone. Science 197, 1187–1189.CrossRefGoogle ScholarPubMed
Mayor, G. H., Sprague, S. M., Hourani, M. R. & Sanchez, T. V. (1980). Parathyroid hormone-mediated aluminum deposition and egress in the rat. Kidney International 17, 40–44.CrossRefGoogle ScholarPubMed
Meyer, J. L., & Thomas, W. C. (1986). Aluminum and aluminum complexes. Effect on calcium phosphate precipitation. Kidney International 29, Suppl. 18, S20–S23.Google Scholar
Milliner, D. S., Shinaberger, J. H., Shuman, P. & Coburn, J. W. (1985). Inadvertent aluminum administration during plasmaexchange due to aluminum contamination of albumin-replacement solutions.New England Journal of Medicine 312, 165–167.CrossRefGoogle Scholar
Morrissey, J., Rothstein, M., Mayor, G. & Slatopolsky, E. (1983). Suppression of parathyroid hormone secretion by aluminum. Kidney International 23, 699–704.CrossRefGoogle ScholarPubMed
Nebeker, H. G., Andress, D. L., Ott, S. M., Alfrey, A. C., Slatopolsky, E., Sherrard, D. J. & Coburn, J. W. (1987). Treatment of aluminum-related bone disease with deferoxamine: results in 51 cases. International Congress of Nephrology 10, London Abstr.Google Scholar
Nordal, K. P., Dahl, E., Thomassen, Y., Brodwall, E. K. & Halse, J. (1988). Seasonal variations in serum aluminum concentration. Pharmacology and Toxicology 62, 80–83.CrossRefGoogle Scholar
Ott, S. M., Andress, D. L., Nebeker, H. G., Milliner, D. S., Maloney, N. A., Coburn, J. W. & Sherrard, D. J. (1986). Changes in bone histology after treatment with desferrioxamine. Kidney International 29, Suppl. 18, S108–S113.Google Scholar
Ott, S. M., Feist, E., Andress, D. L., Liu, C. C., Sherrard, D. J., Alfrey, A. C., Slatopolsky, E. & Howard, G. A. (1987). Development and reversibility of aluminum-induced bone lesion in the rat. Journal of Laboratory and Clinical Medicine 109, 40–47.Google ScholarPubMed
Ott, S. M., Maloney, N. A., Coburn, J. W., Alfrey, A. C. & Sherrard, D. J. (1982). The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy. New England Journal of Medicine 307, 709–713.CrossRefGoogle ScholarPubMed
Ott, S. M., Maloney, N. A., Klein, G. L., Alfrey, A. C., Ament, M. E., Coburn, J. W. & Sherrard, D. J. (1983). Aluminum is associated with low bone formation in patients receiving chronic parenteral nutrition. Annals of Internal Medicine 98, 910–914.CrossRefGoogle ScholarPubMed
Parkinson, I. S., Ward, M. K., Feest, T. G., Fawcett, R. W. P. & Kerr, D. N. S. (1979). Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey. Lancet i, 406–409.CrossRefGoogle Scholar
Perl, D. P. & Brody, A. R. (1980). Alzheimer's disease: X-ray spectrometric evidence of aluminum accumulation in neurofibrillary tangle-bearing neurons. Science 208, 297–299.CrossRefGoogle ScholarPubMed
Perl, D. P., Gajdusek, D. C., Garruto, R. M., Yanagihara, R. T. & Gibbs, C. J. (1982). Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Science 217, 1053–1055.CrossRefGoogle ScholarPubMed
Perl, D. P. & Good, P. F. (1987). Uptake of aluminium into central nervous system along nasal-olfactory pathways. Lancet i, 1028.CrossRefGoogle Scholar
Pierides, A. M., Edwards, W. G., Cullum, U. X., McCall, J. T. & Ellis, H. A. (1980). Hemodialysis encephalopathy with osteomalacic fractures and muscles weakness. Kidney International 18, 115–124.CrossRefGoogle Scholar
Plachot, J. J., Cournot-Witmer, G., Halpern, S., Mendes, V., Bourdeau, A., Fritsch, J., Bourdon, R., Drueke, T., Galle, P. & Balsan, S. (1984). Bone ultrastructure and X-ray microanalysis of aluminum-intoxicated hemodialyzed patients. Kidney International 25, 796–803.CrossRefGoogle ScholarPubMed
Platts, M. M., Goode, G. C. & Hislop, J. S. (1977). Composition of the domestic water supply and the incidence of fractures and encephalopathy in patients on home dialysis. British Medical Journal ii, 657–660.CrossRefGoogle Scholar
Posner, A. S., Blumenthal, N. C. & Boskey, A. L. (1986). Model of aluminum-induced osteomalacia: inhibition of apatite formation and growth. Kidney International 29, Suppl. 18, S17–S19.Google Scholar
Quarles, L. D., Castillo, S. R. & Drezner, M. K. (1989 a). Aluminum-induced replication of osteoblast precursors: a potential mechanism underlying neo-osteogenesis. Journal of Bone and Mineral Research 4, Suppl. 1, S–131 Abstr.Google Scholar
Quarles, L. D., Gitelman, H. J. & Drezner, M. K. (1989 b). Aluminum-induced de novo bone formation in the beagle: a parathyroid hormone-dependent event. Journal of Clinical Investigation 83, 1644–1650.CrossRefGoogle ScholarPubMed
Recker, R. R., Blotcky, A. J., Leffler, J. A. & Rack, E. P. (1977). Evidence for aluminum absorption from the gastrointestinal tract and bone deposition by aluminum carbonate ingestion with normal renal function. Journal of Laboratory and Clinical Medicine 90, 810–815.Google ScholarPubMed
Ribak, C. E., Harris, A. B., Vaughn, J. E. & Roberts, E. (1979). Inhibitory, GABAergic nerve terminals decrease at sites of focal epilepsy. Science 205, 211–214.CrossRefGoogle ScholarPubMed
Robertson, J. A., Felsenfeld, A. J., Haygood, C. C., Wilson, P., Clark, C. & Llach, F. (1983). An animal model of aluminum-induced osteomalacia: role of chronic renal failure. Kidney International 23, 327–335.CrossRefGoogle ScholarPubMed
Sabouraud, O., Chatel, M., Menault, F., Dien-Peron, J., Cartier, F., Garre, M., Gary, J. & Pecker, S. (1978). [Progressivè myoclonic dialysis encephalopathy: clinical, electroencephalographic and neuropathological study. Discussion of pathogenesis.] Revue Neurologique 134, 575–600.Google Scholar
Salusky, I. B., Coburn, J. W., Brill, J., Foley, J., Slatopolsky, E., Fine, R. N. & Goodman, W. G. (1988). Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney International 33, 975–982.CrossRefGoogle ScholarPubMed
Salusky, I. B., Coburn, J. W., Nelson, P. & Goodman, W. G. (1990). Prospective evaluation of aluminum loading from formula in infants with uremia. Journal of Pediatrics 116, 726–729.CrossRefGoogle ScholarPubMed
Salusky, I. B., Coburn, J. W., Paunier, L., Sherrard, D. J. & Fine, R. M. (1984). Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis. Journal of Pediatrics 105, 717–720.CrossRefGoogle ScholarPubMed
Scholtz, C. L., Swash, M., Gray, A., Kogeorgos, J. & Marsh, F. (1987). Neurofibrillary neuronal degeneration in dialysis dementia: a feature of aluminum toxicity. Clinical Neuropathology 6, 93–97.Google ScholarPubMed
Sedman, A. B., Alfrey, A. C., Miller, N. L. & Goodman, W. G. (1987). Tissue and cellular basis for impaired bone formation in aluminum-related osteomalacia in the pig. Journal of Clinical Investigation 79, 86–92.CrossRefGoogle ScholarPubMed
Sedman, A. B. & Klein, G. L. (1990). Aluminum toxicity in childhood. In Aluminum and Renal Failure, pp. 267–274 [DeBroe, M. E. and Coburn, J. W., editors]. Dordrecht: Kluwer Academic Publishers.CrossRefGoogle Scholar
Sedman, A. B., Klein, G. L., Merritt, R. J., Miller, N. L., Weber, K. O., Gill, W. L., Anand, H. & Alfrey, A. C. (1985). Evidence of aluminum loading in infants receiving intravenous therapy. New England Journal of Medicine 312, 1337–1343.CrossRefGoogle ScholarPubMed
Sedman, A. B., Wilkening, G. W., Warady, B. A., Lum, G. M. & Alfrey, A. C. (1984). Encephalopathy in childhood secondary to aluminum toxicity. Journal of Pediatrics 105, 836–838.CrossRefGoogle ScholarPubMed
Semmerkrot, B. A., Monnens, L. A. H. & Baadenhuysen, H. (1989). Levels of aluminium in infant formulae. Lancet i, 1024–1025.Google Scholar
Shankar, S. K., Yanagihara, R., Garruto, R. M., Grundke-Iqbal, I., Kosik, K. S. & Gajdusek, D. C. (1989). Immunocytochemical characterization of neurofibrillary tangles in amyotrophic lateral sclerosis and Parkinsonism-dementia of Guam. Annals of Neurology 25, 146–151.CrossRefGoogle ScholarPubMed
Shike, M., Shils, M. E., Heller, A., Alcock, N., Vigorita, V., Brockman, R., Holick, M. F., Lane, J. & Flombaum, C. (1986). Bone disease in prolonged parenteral nutrition: osteopenia without mineralization defect. American Journal of Clinical Nutrition 44, 89–98.CrossRefGoogle ScholarPubMed
Shike, M., Sturtridge, W. C., Tam, C. S., Harrison, J. E., Jones, G., Murray, T. M., Husdan, H., Whitwell, J., Wilson, D. R. & Jeejeebhoy, K. N. (1981). A possible role of vitamin D in the genesis of parenteral nutrition-induced metabolic bone disease. Annals of Internal Medicine 95, 560–568.CrossRefGoogle ScholarPubMed
Short, A. I. K., Winney, R. J. & Robson, J. S. (1980). Reversible microcytic hypochromic anaemia in dialysis patients due to aluminum intoxication. Proceedings of European Dialysis and Transplantation Association 17, 226–233.Google Scholar
Siegel, N., Suhayda, C. & Haug, A. (1982). Aluminum changes the conformation of calmodulin. Physiological Chemistry and Physics 14, 165–167.Google ScholarPubMed
Simmons, D. J., Seitz, P., Kidder, L. S., Klein, G. L., Waeltz, M., Gundberg, C. M., Tabuchi, C., Yang, C.-Y. & Zhang, R.-W. (1991). Partial characterization of the rat marrow stromal cell. Calcified Tussue International.CrossRefGoogle Scholar
Slanina, P., Falkeborn, Y., Frech, W. & Cedergren, A. (1984). Aluminum concentrations in the brain and bone of rats fed citric acid, aluminium citrate or aluminium hydroxide. Food and Chemical Toxicology 22, 391–397.CrossRefGoogle ScholarPubMed
Slanina, P., Frech, W., Bernhardson, Å., Cedergren, A. & Mattsson, P. (1985). Influence of dietary factors on aluminum absorption and retention in the brain and bone of rats. Acta Pharmacologica et Toxicologica 56, 331–336.CrossRefGoogle ScholarPubMed
Slanina, P., Frech, W., Ekström, L-G., Lööf, L., Slorach, S. & Cedergren, A. (1986). Dietary citric acid enchances absorption of aluminum in antacids. Clinical Chemistry 32, 539–541.Google Scholar
Smith, J. B. (1984). Aluminum ions stimulate DNA synthesis in quiescent cultures of Swiss3T3 and 3T6 cells. Journal of Cellular Physiology 118, 298–304.CrossRefGoogle Scholar
Terry, R. D. & Peña, C. (1965). Experimental production of neurofibrillary degeneration. II. Electron microscopy, phcsphatase histochemistry and electron probe analysis. Journal of Neuropathology and Experimental Neurology 24, 200–210.CrossRefGoogle Scholar
Trapp, G. A. (1986). Interactions of aluminum with cofactors, enzymes, and other proteins. Kidney International 29, Suppl. 18, S12–S16.Google Scholar
Uemura, E. (1984). Intranuclear aluminum accumulation in chronic animals with experimental neurofibrillary changes. Experimental Neurology 85, 10–18.CrossRefGoogle ScholarPubMed
Vargas, J. H., Klein, G. L., Ament, M. E., Ott, S. M., Sherrard, D. J., Horst, R. L., Berquist, W. E., Alfrey, A. C., Slatopolsky, E. & Coburn, J. W. (1988). Metabolic bone disease of total parenteral nutrition: course after changing from casein to amino acids in parenteral solutions with reduced aluminum content. American Journal of Clinical Nutrition 48, 1070–1078.CrossRefGoogle ScholarPubMed
Vukičević, S., Krempien, B. & Stavljenić, A. (1987). Effects of 1-α, 25- and 24 R25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats. Journal of Bone and Mineral Research 2, 533–545.CrossRefGoogle ScholarPubMed
Vukičević, S. & Stavljenić, A. (1989). Aluminum accumulates on inactive bonesurfaces after parathyroidectomy in uremic rats. Hormone and Metabolic Research 21, 15–17.CrossRefGoogle Scholar
Weberg, R. & Berstad, A. (1986). Gastrointestinal absorption of aluminium from single doses of aluminium containing antacids in man. European Journal of Clinical Investigation 16, 428–432.Google ScholarPubMed
Wenk, G. L. & Stemmer, K. L. (1983). Suboptimal dietary zinc intake increases aluminum accumulation into the rat brain. Brain Research 288, 393–395.CrossRefGoogle ScholarPubMed
Williams, J. W., Vera, S. R., Peters, T. G., Luther, R. W., Bhattacharya, S., Spears, H., Graham, A., Pitcock, J. A. & Crawford, A. J. (1986). Biliary excretion of aluminum in aluminum osteodystrophy with liver disease. Annals of Internal Medicine 104, 782–785.CrossRefGoogle ScholarPubMed
Wills, M. R. & Savory, J. (1989). Aluminum and chronic renal failure: sources, absorption, transport, and toxicity. Critical Reviews in Clinical Laboratory Sciences 27, 59–107.CrossRefGoogle ScholarPubMed
Wisniewski, H. M., Shek, J. W., Gruca, S. & Sturman, J. A. (1984). Aluminium-induced neurofibrillary changes in axons and dendrites. Acta Neuropathologica 63, 190–197.CrossRefGoogle Scholar
Yase, Y. (1988). Metal studies of ALS-further development. In Amyotrophic Lateral Sclerosis, pp. 59–66 [Tsubaki, T. and Yase, Y., editors]. Amsterdam: Elsevier Science Publishers.Google Scholar
Yokel, R. A. (1984). Toxicity of aluminum exposure during lactation to the maternal and suckling rabbit. Toxicology and Applied Pharmacology 75, 35–43.CrossRefGoogle ScholarPubMed
You have
Access
- 18
- Cited by